Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles (Q48913327)

16 February 2018

title

Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles (English)

1 reference

16 February 2018

0 references

Filip K Swirski

1 reference

16 February 2018

Ralph Weissleder

1 reference

16 February 2018

Mikael J Pittet

1 reference

16 February 2018

Lee Josephson

series ordinal

object named as

Lee Josephson

1 reference

16 February 2018

author name string

Frederick Reynolds

series ordinal

1 reference

16 February 2018

publication date

1 January 2006

1 reference

16 February 2018

published in

Nature Protocols

1 reference

16 February 2018

volume

1 reference

16 February 2018

issue

1 reference

16 February 2018

page(s)

73-79

1 reference

16 February 2018

Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Ex vivo characterization of allo-MHC-restricted T cells specific for a single MHC-peptide complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Looking and listening to light: the evolution of whole-body photonic imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Scaling down imaging: molecular mapping of cancer in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Adoptive-cell-transfer therapy for the treatment of patients with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

In vivo tracking of tumor-specific T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

In vivo tracking of stem cells for clinical trials in cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Protamine as an efficient membrane-translocating peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Tat-mediated delivery of heterologous proteins into cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

In vivo protein transduction: delivery of a biologically active protein into the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Shedding light onto live molecular targets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Synergistic antitumor effects of immune cell-viral biotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Visualization of a primary anti-tumor immune response by positron emission tomography.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2006.11

31 March 2020

Identifiers

DOI

10.1038/NPROT.2006.11

1 reference

16 February 2018

release_shpwdfesanfr5crak2kdmfsixe

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/shpwdfesanfr5crak2kdmfsixe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 February 2018